OS Therapies

(NYSEMKT) OSTX

Current Price$1.91

Market Cap$77.94M

Since IPO (2024)-30%

5 YearN/A

1 Year+4%

1 Month-1%

OS Therapies Financials at a Glance

Market Cap

$77.94M

Revenue (TTM)

$0.00

Net Income (TTM)

-$35.27M

EPS (TTM)

-$1.03

P/E Ratio

-1.70

Dividend

$0.00

Beta (Volatility)

1.60 (High)

Dividend

$0.00

Beta (Volatility)

1.60 (High)

Price

$1.91

Volume

12,541

Open

$1.81

Price

$1.91

Volume

12,541

Open

$1.81

Previous Close

$1.75

Daily Range

$1.81 - $1.93

52-Week Range

$1.15 - $2.57

Dividend

$0.00

Beta (Volatility)

1.60 (High)

Price

$1.91

Volume

12,541

Open

$1.81

Previous Close

$1.75

Daily Range

$1.81 - $1.93

52-Week Range

$1.15 - $2.57

OSTX News

Os Therapies Posts Wider Loss in Q2

Motley Fool Markets TeamAug 19, 2025

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About OS Therapies

Industry

Biotechnology

Sector

Health Care

Employees

CEO

Paul A. Romness

Website

www.ostherapies.com

Headquarters

Rockville, MD 21638, US

OSTX Financials

Key Financial Metrics (TTM)

Gross Margin

Operating Margin

Net Income Margin

Return on Equity

-914%

Return on Capital

Return on Assets

-5%

Earnings Yield

-58.82%

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

$77.94M

Shares Outstanding

44.54M

Volume

12.54K

Avg. Volume

670.87K

Financials (TTM)

Gross Profit

-$363.09K

Operating Income

-$28.71M

EBITDA

-$28.39M

Operating Cash Flow

-$14.24B

Capital Expenditure

-$466.42K

Free Cash Flow

-$14.24B

Cash & ST Invst.

$269.83M

Total Debt

$0.00

OS Therapies Performance Analysis

Revenue Growth Rate

Annual and quarterly growth comparison

Currently no data to display.

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name

Q1 2026YOY CHG

Revenue

$0.00

N/A

Gross Profit

-$124.94K

N/A

Gross Margin

0.00%

N/A

Market Cap

$77.94M

N/A

Market Cap/Employee

$19.49M

N/A

Employees

N/A

Net Income

-$10.40M

-168.2%

EBITDA

-$10.04M

-159.1%

Quarterly Fundamentals

Name

Q1 2026YOY CHG

Net Cash

-$425.39M

-14418.0%

Accounts Receivable

$0.00

-100.0%

Inventory

$0.00

N/A

Long Term Debt

$0.00

N/A

Short Term Debt

$1.34B

N/A

Return on Assets

-4.83%

N/A

Return on Invested Capital

3.51%

N/A

Free Cash Flow

-$4.56M

-27.1%

Operating Cash Flow

-$4.56M

-32.6%

Other Investments to Explore

People Also Watch

SymbolSymbol / CompanyCompanyPricePrice Chg

NRXPNRx Pharmaceuticals, Inc.

NRXPNRx Pharmaceuticals, Inc.$4.24-1.74%

SPRBSpruce Biosciences, Inc.

SPRBSpruce Biosciences, Inc.$50.36-2.80%

EQEquillium, Inc.

EQEquillium, Inc.$2.68+15.52%

COEPCoeptis Therapeutics, Inc.

COEPCoeptis Therapeutics, Inc.$16.40+0.00%

INKTMiNK Therapeutics, Inc.

INKTMiNK Therapeutics, Inc.$10.28-1.53%

CRVOCervoMed Inc.

CRVOCervoMed Inc.$3.08+0.82%

HOWLWerewolf Therapeutics, Inc.

HOWLWerewolf Therapeutics, Inc.$0.48+4.66%

Trending Stocks

SymbolSymbol / CompanyCompanyPricePrice Chg

ASTCAstrotech

ASTCAstrotech$17.72+6.17%

TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares

TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares$16.35+0.04%

SIDUSidus Space

SIDUSidus Space$5.93-0.04%

RGTIRigetti Computing

RGTIRigetti Computing$24.42-0.03%

MNTSMomentus

MNTSMomentus$18.56+0.20%

NIONio

NIONio$5.77+0.10%

NVDANvidia

NVDANvidia$212.75-0.01%

Questions About OSTX

What is the current price of OS Therapies?

OS Therapies is trading at $1.91 per share.

What is the 52-week range for OS Therapies?

Over the past 52 weeks, OS Therapies has traded between $1.15 and $2.57.

How much debt does OS Therapies have?

As of the most recent reporting period, OS Therapies reported total debt of $1.34M.

How much cash does OS Therapies have on hand?

OS Therapies reported $917.55K in cash and cash equivalents in its most recent financial results.

What is OS Therapies’s dividend yield?

OS Therapies does not currently have a dividend yield.

OS Therapies

OS Therapies Financials at a Glance

OSTX News

Os Therapies Posts Wider Loss in Q2

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

About OS Therapies

OSTX Financials

Key Financial Metrics (TTM)

Stock Overview

Financials (TTM)

OS Therapies Performance Analysis

Revenue Growth Rate

Earnings Per Share Growth Rate

Quarterly Performance

Quarterly Fundamentals

Other Investments to Explore

People Also Watch

Trending Stocks

Questions About OSTX

What is the current price of OS Therapies?

What is the 52-week range for OS Therapies?

How much debt does OS Therapies have?

How much cash does OS Therapies have on hand?

What is OS Therapies’s dividend yield?

Premium Investing Services